TGFB1 and diabetes mellitus: Oral administration of genistein (300 mg/kg/day) in streptozotocin (STZ)-induced diabetic rats showed decreasing in C-reactive protein, HbA1c, blood glucose, and expression of TGF-β1 and NF-α proteins that were increased in STZ-induced diabetes.